(Q49967277)

23 February 2018

title

Hepatotoxic effects of tuberculosis therapy. (English)

1 reference

23 February 2018

1 reference

Juzar Ali

1

1 reference

23 February 2018

language of work or name

English

0 references

publication date

1 May 1996

1 reference

23 February 2018

published in

Postgraduate Medicine

1 reference

23 February 2018

volume

99

1 reference

23 February 2018

issue

5

1 reference

23 February 2018

page(s)

217-236

1 reference

23 February 2018

Isoniazid Preventive Therapy for Tuberculosis: Decision Analysis Considering Ethnicity and Gender

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1996.11946128

Factors in hydrazine formation from isoniazid by paediatric and adult tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1996.11946128

Perspective: preventive isoniazid therapy and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1996.11946128

Anti-tuberculous therapy and acute liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1996.11946128

Antituberculosis treatment-induced hepatotoxicity: role of predictive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1996.11946128

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1996.11946128

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1996.11946128

10.1080/00325481.1996.11946128

21 January 2018

Identifiers

DOI

1 reference

23 February 2018

1 reference

23 February 2018